Peer-reviewed, open-access, and globally focused – Bionatura Journal publishes cutting-edge research in biotechnology, medicine, and environmental sciences.
At Bionatura Journal, we are committed to upholding the highest standards of quality and scientific rigor. We employ a strict double-blind peer review process and feature a highly qualified, internationally recognized, and top-tier Editorial Board composed of leading experts in their respective fields. This elite team is fundamental to ensuring the academic excellence and editorial integrity of every publication. Furthermore, we strictly adhere to COPE ethical standards and conduct thorough checks for plagiarism and AI-generated content to ensure the originality and highest quality of every manuscript.
BioNatura Journal is an open-access journal that makes all articles freely available under the Creative Commons Attribution 4.0 (CC BY 4.0) license.
We are currently indexed in:
All articles are immediately disseminated to Academia.edu, reaching a broad audience of researchers and professionals. This ensures wider exposure and higher citation potential, enhancing the impact of your research.
BioNatura Journal plans to apply for inclusion in Scopus and Web of Science in January 2026, once it meets the minimum required publication period of two years.
Key Benefits of Inclusion:
We welcome original research, reviews, and short communications from around the world
Clinical Biotec S.L. – Spanish Tax ID (CIF): B56379233
Based in Madrid, Spain.
Registered in the Mercantile Registry of Madrid. We act as commercial representatives and authorized distributors for national and international companies in the technological, editorial, scientific, and academic sectors.
Email: santiago@clinicalbiotec.com | wanfangdata@clinicalbiotec.com
Copyright © 2023–2025 Clinical Biotec. All rights reserved.